NCT05176067

Randomized Controlled Clinical Study of Drug Therapy Combined With Thoracic Radiotherapy for Non-oligometastatic NSCLC

Department of Thoracic Oncology, Affiliated Tumor Hospital of Guizhou Medical University

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 88 (estimated)
• Sponsor: Guizhou Medical University · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Accepted

Summary

To investigate whether radiotherapy combined with drug therapy is beneficial to non- oligometastatic stage IV NSCLC

Detailed description

Group A (targeted therapy, immunotherapy, chemotherapy); The efficacy was evaluated after the second and fourth cycles of chemotherapy and immunotherapy; The efficacy of targeted therapy was evaluated every month; Group B (drug concurrent radiotherapy group: combined with thoracic primary tumor radiotherapy on the basis of targeted therapy, immune, chemotherapy ) The efficacy was evaluated after the second and fourth cycles of chemotherapy and immunotherapy; The efficacy of targeted therapy was evaluated every month; Radiographic evaluation was performed after radiotherapy for the primary lesion of the chest.

Conditions

• Stage IV Non-small Cell Lung Cancer

Interventions

Type	Name	Description
RADIATION	Thoracic Three-dimensional Radiotherapy	Drug Therapy Combined With Thoracic Three-dimensional Radiotherapy

Timeline

• Start date: 2021-12-30
• Primary completion: 2023-12-31
• Completion: 2023-12-31
• First posted: 2022-01-04
• Last updated: 2022-01-04